Core Insights - Jupiter Neurosciences, Inc. has launched Nugevia PWR, a mitochondrial health supplement aimed at supporting cellular energy, endurance, and recovery, targeting a growing market projected to reach $8 trillion by 2030 [1][4][6] Product Overview - Nugevia PWR is formulated with JOTROL and a blend of mitochondrial support ingredients to optimize energy production, protect against oxidative stress, and enhance physical performance [2][6] - The supplement is designed for adults seeking sustained strength and metabolic resilience, with a recommended dosage of two capsules per day for optimal compliance [5][6] Scientific Basis - JOTROL has shown a nine-fold increase in resveratrol bioavailability in Phase I trials, promoting mitochondrial biogenesis and energy metabolism [3][9] - The formulation includes NovaSOL solubilized CoQ10, enhancing mitochondrial energy production and muscle function, creating a synergy that improves energy, endurance, and muscle recovery [3][6] Strategic Positioning - PWR aligns with Jupiter's strategy to monetize its proprietary science across pharmaceutical and consumer markets, serving as a high-margin revenue driver [4][5] - The Nugevia product line represents both scientific achievement and a strategic revenue opportunity, differentiating itself in the crowded energy supplement space [5][6] Company Background - Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on neuroinflammation and healthy aging, with a therapeutic pipeline targeting CNS disorders and a consumer longevity market expansion [6][10]
Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery